Differential Expression of Liver Interleukin-6 Receptor-α in Female Versus Male Ethanol-Consuming Rats

Alcoholism: Clinical and Experimental Research

Volumn 28, Issue 3, 2004, Pages 365-373

  Gallucci, Randle M ^a   Sloan, Dusti K ^a   O'Dell, Sijy J ^a   Reinke, Lester A ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Gender; I B; IL 6R; Inflammation; Liver

Indexed keywords

I KAPPA B; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 6 RECEPTOR ALPHA; MESSENGER RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; WESTERN BLOTTING;

ALCOHOL DRINKING; ANIMALS; ETHANOL; FEMALE; GENE EXPRESSION REGULATION; LIVER; MALE; RATS; RATS, WISTAR; RECEPTORS, INTERLEUKIN-6; SEX CHARACTERISTICS;

ANIMALIA;

EID: 1642352662     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000118316.20560.0D     Document Type: Article

References (50)

1. Aljada A, Ghanim H, Assian E, Mohanty P, Hamouda W, Garg R, Dandona P (1999) Increased IkappaB expression and diminished nuclear NF-kappaB in human mononuclear cells following hydrocortisone injection. J Clin Endocrinol Metab 84:3386-3389.
2. Azuma M, Motegi K, Aota K, Yamashita T, Yoshida H, Sato M (1999) TGF-beta1 inhibits NF-kappaB activity through induction of IkappaB-alpha expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-beta1. Exp Cell Res 250:213-222.
3. Barut B, Chauhan D, Uchiyama H, Anderson KC (1993) Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro. J Clin Invest 92:2346-2352.
4. Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF, Schnohr P, Jensen G (1996) Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 23:1025-1029.
5. Bruccoleri A, Gallucci R, Germolec DR, Blackshear P, Simeonova P, Thurman RG, Luster MI (1997) Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity. Hepatology 25:133-141.
6. Chen J, Clemens DL, Cederbaum AI, Gao B (2001) Ethanol inhibits the JAK-STAT signaling pathway in freshly isolated rat hepatocytes but not in cultured hepatocytes or HepG2 cells: evidence for a lack of involvement of ethanol metabolism. Clin Biochem 34:203-209.
7. Chen J, Kunos G, Gao B (1999) Ethanol rapidly inhibits IL-6-activated STAT3 and C/EBP mRNA expression in freshly isolated rat hepatocytes. FEBS Lett 457:162-168.
8. Choi I, Kang HS, Yang Y, Pyun KH (1994) IL-6 induces hepatic inflammation and collagen synthesis in vivo. Clin Exp Immunol 95:530-535.
9. Cornell NW, Veech RL (1983) Enzymatic measurement of ethanol or NAD in acid extracts of biological samples. Anal Biochem 132:418-423.
10. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274:1379-1383.
11. Daniluk J, Szuster-Ciesielska A, Drabko J, Kandefer-Szerszen M (2001) Serum cytokine levels in alcohol-related liver cirrhosis. Alcohol 23:29-34.
12. Deaciuc IV, Alappat JM, D'Souza NB (1994) Effect of acute and chronic alcohol administration to rats on the expression of interleukin-6 cell-surface receptors of hepatic parenchymal and nonparenchymal cells. Alcohol Clin Exp Res 18:1207-1214.
13. French SW (2001) Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease. J Biomed Sci 8:20-27.
14. French SW, Tsukamoto H (1989) Animal models for alcoholic liver disease. Hepatology 10:898-899.
15. Gallucci RM, Simeonova PP, Matheson JM, Kommineni C, Guriel JL, Sugawara T, Luster MI (2001) Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J 14:2525-2531.
16. Giannitrapani L, Cervello M, Soresi M, Notarbartolo M, La Rosa M, Virruso L, D'Alessandro N, Montalto G (2002) Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma. Ann NY Acad Sci 963:46-52.
17. Gonzalez-Quintela A, Vidal C, Lojo S, Perez LF, Otero-Anton E, Gude F, Barrio E (1999) Serum cytokines and increased total serum IgE in alcoholics. Ann Allergy Asthma Immunol 83:61-67.
18. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 29:1-20.
19. Honda M, Yamamoto S, Cheng M, Yasukawa K, Suzuki H, Saito T, Osugi Y, Tokunaga T, Kishimoto T (1992) Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 148:2175-2180.
20. Hong F, Kim WH, Tian Z, Jaruga B, Ishac E, Shen X, Gao B (2002) Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 21:32-43.
21. Ikejima K, Enomoto N, Iimuro Y, Ikejima A, Fang D, Xu J, Forman DT, Brenner DA, Thurman RG (1998) Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin. Am J Physiol 274:G669-G676.
22. Ito H (2003) IL-6 and Crohn's disease. Curr Drug Targets Inflamm Allergy 2:125-130.
23. Jones SA, Rose-John S (2002) The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex. Biochim Biophys Acta 1592:251-263.
24. Kamohara Y, Sugiyama N, Mizuguchi T, Inderbitzin D, Lilja H, Middleton Y, Neuman T, Demetriou AA, Rozga J (2000) Inhibition of signal transducer and activator transcription factor 3 in rats with acute hepatic failure. Biochem Biophys Res Commun 273:129-135.
25. Keller ET, Chang C, Ershler WB (1996) Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. J Biol Chem 271:26267-26275.
26. Kono H, Wheeler MD, Rusyn I, Lin M, Seabra V, Rivera CA, Bradford BU, Forman DT, Thurman RG (2000) Gender differences in early alcohol-induced liver injury: role of CD14, NF-kappaB, and TNF-alpha. Am J Physiol Gastrointest Liver Physiol 278:G652-G661.
27. Koteish A, Yang S, Lin H, Huang X, Diehl AM (2002) Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation. J Biol Chem 277:13037-13044.
28. Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R (2000) Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 31:149-159.
29. Li W, Liang X, Kellendonk C, Poli V, Taub R (2002) STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 277:28411-28417.
30. McKay LI, Cidlowski JA (1999) Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 20:435-459.
31. Meng ZH, Dyer K, Billiar TR, Tweardy DJ (2000) Distinct effects of systemic infusion of G-CSF vs. IL-6 on lung and liver inflammation and injury in hemorrhagic shock. Shock 14:41-48.
32. Nakajima K, Matsuda T, Fujitani Y, Kojima H, Yamanaka Y, Nakae K, Takeda T, Hirano T (1995) Signal transduction through IL-6 receptor: involvement of multiple protein kinases, stat factors, and a novel H7-sensitive pathway. Ann NY Acad Sci 762:55-70.
33. National Research Council (1985) Guide for the Care and Use of Laboratory Animals (NIH Publication 85-23). US Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD.
34. Omoya T, Shimizu I, Zhou Y, Okamura Y, Inoue H, Lu G, et al. (2001) Effects of idoxifene and estradiol on NF-kappaB activation in cultured rat hepatocytes undergoing oxidative stress. Liver 21:183-191.
35. Pallua N, Low JF, Von Heimburg D (2003) Pathogenic role of interleukin-6 in the development of sepsis. Part II: significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model. Crit Care Med 31:1495-1501.
36. Peters M, Jacobs S, Ehlers M, Vollmer P, Mullberg J, Wolf E, Brem G, Meyer zum Buschenfelde KH, Rose-John S (1996) The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp Med 183:1399-1406.
37. Schirmacher P, Peters M, Ciliberto G, Blessing M, Lotz J, Meyer zum Buschenfelde KH, Rose-John S (1998) Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice. Am J Pathol 153:639-648.
38. Simeonova PP, Luster MI (1996) Asbestos induction of nuclear transcription factors and interleukin 8 gene regulation. Am J Respir Cell Mol Biol 15:787-795.
39. Simoncini T, Maffei S, Basta G, Barsacchi G, Genazzani AR, Liao JK, De Caterina R (2000) Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res 87:19-25.
40. Sun WH, Keller ET, Stebler BS, Ershler WB (1998) Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation. Biochem Biophys Res Commun 244:691-695.
41. Swartz KR, Liu F, Sewell D, Schochet T, Campbell I, Sandor M, Fabry Z (2001) Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res 896:86-95.
42. Thurman RG (2000) Sex-related liver injury due to alcohol involves activation of Kupffer cells by endotoxin. Can J Gastroenterol 14:129D-135D.
43. Trovato M, Grosso M, Vitarelli E, Ruggeri RM, Alesci S, Trimarchi F, Barresi G, Benvenga S (2003) Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas. Histol Histopathol 18:393-399.
44. Tsukamoto H, Towner SJ, Ciofalo LM, French SW (1986) Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology 6:814-822.
45. Uesugi T, Froh M, Arteel GE, Bradford BU, Gabele E, Wheeler MD, Thurman RG (2001) Delivery of IkappaB superrepressor gene with adenovirus reduces early alcohol-induced liver injury in rats. Hepatology 34:1149-1157.
46. Vladic A, Horvat G, Vukadin S, Sucic Z, Simaga S (2002) Cerebrospinal fluid and serum protein levels of tumour necrosis factor-alpha (TNF-alpha) interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R gp80) in multiple sclerosis patients. Cytokine 20:86-89.
47. Wang YF, Chang SY, Tai SK, Li WY, Wang LS (2002) Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. Head Neck 24:850-858.
48. Wong PK, Campbell IK, Egan PJ, Ernst M, Wicks IP (2003) The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover. Arthritis Rheum 48:1177-1189.
49. Wuestefeld T, Klein C, Streetz KL, Betz U, Lauber J, Buer J, Manns MP, Muller W, Trautwein C (2003) Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 278:11281-11288.
50. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101:311-320.